Miulli General Hospital
Welcome,         Profile    Billing    Logout  
 7 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grimaldi, Massimo
EMPA-AF, NCT04583813: Empagliflozin and Atrial Fibrillation Treatment

Not yet recruiting
4
400
Europe
Empagliflozin, Empagliflozin 10 mg oral tablet, Placebo, Placebo oral tablet
Miulli General Hospital
Atrial Fibrillation, Heart Failure, Obesity, Diabetes Mellitus
01/24
04/24
STARAF3, NCT04428944: STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation

Recruiting
N/A
615
Europe, Canada, Japan, US, RoW
Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI), Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers), Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box)
McGill University Health Centre/Research Institute of the McGill University Health Centre, Montreal Heart Institute
Atrial Fibrillation
08/26
01/27
Gregucci, Fabiana
NCT04810182: Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Completed
N/A
192
Europe
Regorafenib 40 MG Oral Tablet [STIVARGA]
Istituto Oncologico Veneto IRCCS
Glioblastoma Multiforme
12/23
12/23
Monaco, Antonio
EMPA-AF, NCT04583813: Empagliflozin and Atrial Fibrillation Treatment

Not yet recruiting
4
400
Europe
Empagliflozin, Empagliflozin 10 mg oral tablet, Placebo, Placebo oral tablet
Miulli General Hospital
Atrial Fibrillation, Heart Failure, Obesity, Diabetes Mellitus
01/24
04/24
niPGT-A_RCT, NCT04000152: RCT Study to Validate niPGT-A Clinical Benefit.

Recruiting
N/A
1108
Europe, US, RoW
niPGT-A, Morphology criteria
Igenomix
Aneuploidy, Chromosome Abnormality, Infertility
02/25
06/25
Katsouras, Grigorios
HIPPOS, NCT05491655: High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study

Recruiting
N/A
34
Europe
High Intensity His Bundle pacing
Miulli General Hospital
Cardiac Conduction System, His Bundle Pacing, Heart Failure, Cardiomyopathies
02/25
02/25
Fiorentino, Alba
TiMiSNaR, NCT03465982: Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer

Recruiting
N/A
340
Europe
Surgery after 8 weeks from chemoradiation treatment, Surgery after 12 weeks from chemoradiation treatment
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Rectal Cancer
06/25
06/29

Download Options